Cargando…
Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report
Autores principales: | Ehrlich, Peter, Klingel, Karin, Ohlmann-Knafo, Susanne, Hüttinger, Sebastian, Sood, Nitin, Pickuth, Dirk, Kindermann, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419377/ https://www.ncbi.nlm.nih.gov/pubmed/34487236 http://dx.doi.org/10.1007/s00392-021-01936-6 |
Ejemplares similares
-
Predictors of Mortality in Patients With Biopsy‐Proven Viral Myocarditis: 10‐Year Outcome Data
por: Greulich, Simon, et al.
Publicado: (2020) -
Endomyocardial biopsy-proven fulminant lymphocytic myocarditis presenting with mid-apical ballooning
por: Miyamoto, Ryota, et al.
Publicado: (2023) -
Using Multiparametric Cardiac Magnetic Resonance to Phenotype and Differentiate Biopsy-Proven Chronic from Healed Myocarditis and Dilated Cardiomyopathy
por: Krumm, Patrick, et al.
Publicado: (2022) -
Sex differences in natural history of cardiovascular magnetic resonance‐ and biopsy‐proven lymphocytic myocarditis
por: Castrichini, Matteo, et al.
Publicado: (2022) -
Myocarditis following mRNA COVID‐19 vaccination: call for endomyocardial biopsy
por: Kiblboeck, Daniel, et al.
Publicado: (2022)